 Provider News IndianaSeptember 2024 Provider Newsletter Contents Education & Training | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | August 23, 2024 How are we doing?Prior Authorization | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | August 23, 2024 Hospice notification updates
INBCBS-CDCRCM-065285-24 HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). Administrative | Commercial | August 7, 2024 Change to Prior Authorization Requirements Enhanced claims edits system for drug quality checksSummary:- Effective November 1, 2024, Anthem plans to enhance its claims edits system to ensure that pharmaceutical drug procedure codes are aligned with FDA-approved indicators for on- and off-label use.
- These improvements will allow Anthem to evaluate submitted claims for drug quality, safety, and effectiveness more accurately.
- If a claim reimbursement decision requires review, care providers should follow the traditional claims dispute process and include relevant medical records.
Effective November 1, 2024, Anthem is enhancing its claims edits system to ensure that claims billed with pharmaceutical drug procedure codes are reported with the appropriate FDA-approved indicators for on- and off-label use. These enhanced claim edits provide an opportunity for Anthem to evaluate submitted claims for drug quality, safety, and effectiveness. If you believe a claim reimbursement decision should be reviewed, please follow the normal claims dispute process outlined in the provider manual and include medical records that clarify whether the indication was approved through the governing agencies. You will only need to submit the portion(s) of the medical record relevant to the drug provided. If you have questions about this notification, contact your contract manager or provider relationship management account representative. Together, we can work towards improved outcomes. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-063316-24-CPN63316 Claims that are submitted for laboratory services subject to the Clinical Laboratory Improvement Amendments of 1988 (CLIA) statute and regulations require additional information to be considered for payment. To be considered for reimbursement of clinical laboratory services, a valid CLIA certificate identification number must be reported on a 1500 Health Insurance Claim Form (CMS-1500) or its electronic equivalent for clinical laboratory services. The CLIA certificate identification number must be submitted in one of the following manners: Claim format and elements | CLIA number location options | Referring provider name and NPI number location options | Servicing laboratory physical location | CMS-1500 (formerly HCFA-1500) | Must be represented in field 23 | Submit the referring provider name and NPI number in fields 17 and 17b, respectively. | Submit the servicing provider name, full physical address and NPI number in fields 32 and 32A, respectively, if the servicing address is not equal to the billing provider address. The servicing provider address must match the address associated with the CLIA ID entered in field 23. | HIPAA 5010 837 Professional | Must be represented in the 2300 loop, REF02 element, with qualifier of X4 in REF01 | Submit the referring provider name and NPI number in the 2310A loop, NM1 segment. | Physical address of servicing provider must be represented in the 2310C loop if not equal to the billing provider address and must match the address associated with the CLIA ID submitted in the 2300 loop, REF02. |
To be considered for reimbursement of reference laboratory services, the referring laboratory must be an independent clinical laboratory. Modifier 90 must be submitted to denote the referred laboratory procedure. Per the Centers for Medicare & Medicaid (CMS), an independent clinical laboratory that submits claims in paper format may not combine non-referred or self-performed and referred services on the same CMS-1500 claim form. Thus, when the referring laboratory bills for both non-referred and referred tests, it must submit two separate paper claims: one claim for non-referred tests and the other for referred tests. If submitted electronically, the reference laboratory must be represented in the 2300 or 2400 loop, REF02 element, with qualifier of F4 in REF01. Providers who have obtained a CLIA Waiver or Provider Performed Microscopy Procedure accreditation must include the QW modifier when any CLIA waived laboratory service is reported on a CMS-1500 claim form. Laboratory procedures must be rendered by an appropriately licensed or certified laboratory having the appropriate level of CLIA accreditation for the particular test performed. Thus, any claim that does not contain the CLIA ID, has an invalid ID, has a lab accreditation level that does not support the billed service code, does not have complete servicing provider demographic information and/or applicable reference laboratory provider demographic information, will be considered incomplete and rejected or denied. If you have questions, please contact your Provider Relationship Management representative. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CRCM-029658-23-CPN29126, MULTI-BCBS-CRCM-066936-24 Digital Solutions | Commercial / Medicare Advantage / Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | September 1, 2024 Save time and get better results with optimized CPT code search in Availity EssentialsImprovements in search capabilities in Availity Essentials now result in faster and more accurate results. To help save you more time upfront while receiving more detailed eligibility and benefits information, we’ve expanded the Current Procedural Terminology® (CPT) code search capabilities in Availity Essentials’ Eligibility and Benefit app. These optimizations enable the use of up to eight specific CPT or HCPCS codes per transaction for faster, more accurate, and personalized search results, which include: - Authorization requirement notifications, so you know up-front if an authorization is needed.
- Additional plan-level benefit limitations details.
- Cost-share information displayed by places of service and procedure codes.
Making these details available on the search results pages can help you save time and effort by giving you access to the right information you need when you need it. Additionally, it reduces the need to contact us, resulting in fewer calls and chats over time. Watch the recorded training to see how you can start saving time today. Learning sessions show step-by-step how you can use the CPT code search capabilities in Availity Essentials to help increase your productivity. We're dedicated to supporting your success through digital solutions that help reduce your administrative burden and streamline your interactions with us. If you have any questions, contact your provider relationship management representative. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CDCRCM-062264-24-CPN60904 Digital Solutions | Medicare Advantage / Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | August 23, 2024 Coming soon — digital-only authorization case status notificationsWe have previously communicated to you that we are digitizing the authorization case notifications regarding status and decision letters, eliminating paper notifications, with the commercial health plans. We are happy to share with you that we are now also expanding the digitization of authorization case notifications for Medicare Advantage and Medicaid plans from Anthem in your state. Just as you have with commercial health plans, you have 24/7 access to authorization case information in one location through Availity Essentials. The digital authorization case status notifications are available under the Authorizations and Referrals* application once you have logged in to Availity Essentials and selected Patient Registration. By eliminating the redundancy of receiving both a digital and paper letter, you’ll see fewer errors associated with manual processes in handling the paper letters while reducing cost and our carbon footprint. * Note: your Availity Essentials administrator must assign you the role of Authorization & Referral Inquiry or Request to access this application. Care providers will be able to choose different options to receive authorization decision notifications via the Provider Preference Center under Availity Payer Spaces. Look for details on the Provider Preference Center options and ways to access authorization case status in an upcoming communication. We are focused on reducing administrative burdens, so you can do what you do best — care for your patients. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CDCR-051361-24-CPN51281 Education & Training | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | August 23, 2024 How are we doing?We want to know what is important to you, our care providers, as we continue to focus on improving the health of Hoosiers by being the most innovative, valuable, and inclusive partner. The 2024 Indiana Medicaid Provider Satisfaction Surveys will go out within the next few weeks. Our vendor, Center for the Study of Services (CSS), will email or fax the surveys to you. Results from the survey will help identify areas that we serve effectively, but most importantly, it will help to identify areas of opportunity to better serve you and our members. If you receive a survey, we highly encourage you to complete it. Your responses are greatly appreciated and will be kept completely confidential. To ensure we are aligned with our provider network needs, we strive to improve areas of opportunity in the areas listed below: - Claims processing and reimbursement
- Utilization management
- Population health (case and disease management)
- Training and education
- Communications
- Provider Services
- Continuity and coordination of care
- Cultural competency
We look forward to continuing partnering with you as we offer the highest quality of healthcare to our members. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-065919-24 Education & Training | Commercial / Medicare Advantage / Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | September 1, 2024 Coming soon: Provider e-Learning Resource Center for Payment IntegrityWe are thrilled to announce the upcoming launch of Payment Integrity's new innovative tool, the Provider e-Learning Resource Center (PeRC). This is an exciting upgrade exemplary of our ongoing commitment to providing the best resources for your billing and coding success. PeRC is an educational platform: - Dedicated to accurate coding initiatives, with the goal of resulting in reduced errors.
- That promotes a well-informed care provider community, enhances healthcare services, and improves outcomes.
Stay tuned for the official launch date and more details about the Provider e-Learning Resource Center from the Provider Education team. We are committed to a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CDCRCM-061015-24-CPN60941 Fifty-three million, or more than one in five Americans, are family caregivers. Caregiving in the U.S. 2020 reports that caregivers face health challenges of their own, with nearly a quarter of caregivers finding it hard to take care of their own health and saying that caregiving has made their own health worse. Now, we have made it easy for providers to help their patients who are family caregivers reduce their stress and improve their health. Help for Cancer Caregivers’ new healthcare provider landing page has an easy-to-download flyer that can be given to patients to encourage them to visit Help for Cancer Caregivers. This evidence-based, interactive website allows family caregivers to take a brief survey to create a personal self-care guide, access social services, and browse topics like dealing with feelings, keeping health, day-to-day needs, working together, and long-distance caregiving. Studies show that family caregivers suffer from poorer physical health than those who do not have additional caregiving responsibilities. Studies have found that: - Caregivers show higher levels of depression.
- Caregivers suffer from high levels of stress and frustration, which can lead to burnout.
- Stressful caregiving situations may lead to harmful behaviors, such as abusing drugs or alcohol.
- Caregivers have an increased risk of heart disease.
- Caregivers have lower levels of self-care.
- Chronic diseases of caregivers are often more difficult to manage.
- Caregivers have an increased risk of sickness and premature death.
Evidence has also shown that education and intervention reduce caregiver strain, uncertainty, and helplessness and that information helps normalize the caregiver experience and enhances a sense of control. Access the healthcare provider landing page today. This website includes language and accessibility tools to support non-English speakers and people with accessibility needs. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-064165-24-CPN64037 Medical Policy & Clinical Guidelines | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | August 20, 2024 Medical Policies and Clinical Utilization Management Guidelines updateEffective October 10, 2024 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Q4 2023. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary. Please share this notice with other providers in your practice and office staff. To view a guideline, visit anthem.com/provider/policies/clinical-guidelines/search/. Clinical UM GuidelinesOn November 9, 2023, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicaid members on January 4, 2024. These guidelines take effect October 10, 2024. Publish Date | Clinical UM Guideline Number | Clinical UM Guideline Title | New or Revised | 12/28/2023 | CG-SURG-95 | Sacral Nerve Stimulation and Percutaneous or Implantable Tibial Nerve Stimulation for Urinary and Fecal Incontinence, Urinary Retention | Revised |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-056955-24-CPN56516 Medical Policy & Clinical Guidelines | Commercial | August 14, 2024 Change to Prior Authorization Requirements Medical Policies and Clinical UM Guidelines updates — September 2024The following Medical Policies and Clinical UM Guidelines were reviewed for Indiana, Kentucky, Missouri, Ohio, and Wisconsin. To view medical policies and utilization management guidelines, go to anthem.com > select Providers > select your state > under Provider Resources > select Policies, Guidelines & Manuals. To help determine if prior authorization is needed for Anthem members, go to anthem.com > select Providers > select your state > under Claims > select Prior Authorization. You can also call the prior authorization phone number on the back of the member’s ID card. To view medical policies and utilization management guidelines applicable to members enrolled in the Blue Cross and Blue Shield Service Benefit Plan (commonly referred to as the Federal Employee Program® FEP), please visit fepblue.org > Policies & Guidelines. Below are the new medical policies and/or clinical guidelines that have been approved. * Denotes prior authorization required Policy/guideline | Information | Effective date | *MED.00148 Gene Therapy for Metachromatic Leukodystrophy | - Outlines the MN and NMN criteria for gene therapy for metachromatic leukodystrophy
- New technology No specific code for Lenmeldy, listed NOC codes C9399, J3490, J3590
| 12/1/2024 | *RAD.00069 Absolute Quantitation of Myocardial Blood Flow Measurement | - The use of absolute quantitation of myocardial blood flow testing is considered INV&NMN for all indications
- Existing CPT® codes 0742T and 78434 and new CPT codes 0899T, 0900T effective 07/01/2024 will be considered INV&NMN
| 12/1/2024 | *SURG.00011 Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | - Revised ocular indications, including the addition of SurSight to MN and NMN section and added new MN criterion addressing non-healing or persistent corneal epithelial defects
- Removed VersaWrap from INV&NMN statement
- Removed Phasix Mesh from INV&NMN statement
- Added Phasix Mesh and Phasix ST Mesh to MN and NMN statements
- Revised coding section for ocular indications to considered MN when criteria are met; no specific code for Phasix, included in listed NOC codes; added new HCPCS codes Q4311-Q4333 effective 07/01/2024 considered INV&NMN and removed deleted codes Q4210, Q4277
| 12/1/2024 |
Below are the current clinical guidelines and/or medical policies we reviewed, and updates were approved. * Denotes prior authorization required Policy/guideline | Information | Effective date | *LAB.00019 Proprietary Algorithms for Liver Fibrosis | Added new CPT PLA code 0468U effective 07/01/2024 for the NASHnext test, considered INV&NMN | 7/1/2024 | *LAB.00042 Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy | Added new CPT PLA code 0456U effective 07/01/2024 for PrismRA test considered INV&NMN, replacing NOC codes | 7/1/2024 | *LAB.00046 Testing for Biochemical Markers for Alzheimer's Disease | Added new CPT PLA code 0459U effective 07/01/2024 for Elecsys® Total Tau CSF (tTau) and β-Amyloid (1-42) CSF II (Abeta 42) Ratio, considered INV&NMN | 7/1/2024 | *MED.00013 Parenteral Antibiotics for the Treatment of Lyme Disease | - Revised MN criteria related to heart blocks
- Revised formatting in Clinical Indications section
Added existing HCPCS codes J0688, J0689, J0744, J2184, J2281 and new codes J0687, J2183 effective 07/01/2024, for brand non-equivalent products considered INV&NMN for Lyme disease | 7/1/2024 | *MED.00140 Gene Therapy for Beta Thalassemia | Added HCPCS code J3393 effective 07/01/2024 for Zynteglo (replacing NOC codes for Zynteglo) | 7/1/2024 | *MED.00146 Gene Therapy for Sickle Cell Disease | Added HCPCS code J3394 effective 07/01/2024 for Lyfgenia (replacing NOC codes for Lyfgenia) | 7/1/2024 | *SURG.00052 Percutaneous Vertebral Disc Procedures Previously titled: Percutaneous Vertebral Disc and Vertebral Endplate Procedures | - Revised Title
- Removed MN and NMN criteria for intraosseous basivertebral nerve ablation (BVNA) from Position Statement (other criteria available)
Criteria for intraosseous basivertebral nerve ablation (BVNA) have been transitioned to Carelon Medical Benefits Management Musculoskeletal guidelines Removed CPT codes 64628, 64629 and associated ICD-10-PCS codes | 9/1/2024 | *TRANS.00039 Portable Normothermic Organ Perfusion Systems | Added new CPT Category III codes 0894T, 0895T, 0896T effective 07/01/2024 for liver perfusion systems MN when criteria are met, replacing NOC code | 7/1/2024 |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-064737-24 Prior Authorization | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | August 23, 2024 Hospice notification updatesEffective October 25, 2024, our Medicaid plans will align with Indiana Health Coverage Program (IHCP) fee-for-service (FFS) for hospice services for the following programs: Healthy Indiana Plan, Hoosier Care Connect, and Indiana PathWays for Aging. This includes the following covered services: home hospice, hospice in a nursing facility (includes room and board), hospice in a hospice facility, and respite hospice care. The following changes will be applied to all hospice services. All hospice care providers must send notification of services. For dually eligible (Medicare and Medicaid) hospice members, hospice care providers should refer to eligibility requirements in Code of Federal Regulations 42 CFR 418.20, which states: In order to be eligible to elect hospice care under Medicare, an individual must be: (a) Entitled to Part A of Medicare; and (b) Certified as being terminally ill in accordance with 418.22. Medicaid-only (non-dual) hospice members must be eligible for the Medicaid program and be certified as terminally ill in accordance with 42 CFR 418.22. Furthermore, the medical documentation contained in the form Medicaid Hospice Physician Certification (state form 48736 [R/12-02]/OMPP 0006) and the form Medicaid Hospice Plan of Care (state form 48731 [R2/11-04]/OMPP 0011) must support a terminal diagnosis versus a chronic condition. Continuity of care (COC) notificationsFax the required documentation to 844-765-5157. The notification must contain: - IHCP prior authorization (PA) form, including:
- CPT®/HCPCS code applicable to the hospice service (see below for codes).
- Do not list revenue codes on the PA form.
- In the note section of the IHCP PA form, enter COC.
- The approval letter from FFS or previous MCE containing the allowed units and dates of service:
- COC dates of service will begin the date the member became eligible and approved for 90 days.
- If the previously approved service ends prior to the 90th day, the end date of service will follow the approved end date.
- If services need to continue after the COC period:
- Submit the notification 14 days before the COC period expires.
- Include the documentation as outlined below.
Notification of dual membersService: hospice in a nursing facility or in a hospice facility Submit the following documentation by fax to 844-765-5157: - IHCP PA form, including:
- The nursing facility or hospice facility National Payer Identifier (NPI) and tax ID (enter in the note section of the PA form).
- Enter a CPT/HCPCS code (one of the following codes must be listed: Q5003, Q5004, Q5006, Q5007, or T2046).
- Do not include revenue codes on the IHCP PA form.
- Your billing will not be impacted by listing the CPT/HCPCS codes on the IHCP PA form since care providers bill with revenue codes.
- Hospice election form
- MD signed certification for terminal illness with less than six months of life expectancy
- Hospice authorization for dually eligible nursing facility residents’ form
Notification for non-dual membersService: hospice in a nursing facility or in a hospice facility Submit the following documentation by fax to 844-765-5157: - IHCP PA form, including:
- The nursing facility or hospice facility NPI and tax ID (enter in the note section of the PA form)
- Enter a CPT/HCPCS code (one of the following codes must be listed: Q5003, Q5004, Q5006, Q5007, or T2046).
- Do not include revenue codes on the IHCP PA form.
- Your billing will not be impacted by listing the CPT/HCPCS codes on the IHCP PA form since care providers bill with revenue codes.
- Hospice election form
- MD signed certification for terminal illness with less than six months of life expectancy
Notification for all membersService: home hospice and continuous home hospice Submit the following documentation by fax to 844-765-5157: - IHCP PA form, including:
- Enter a CPT/HCPCS code (one of the following codes must be listed: Q5001, T2042, or T2043)
- Do not include revenue codes on the IHCP PA form.
- Your billing will not be impacted by listing the CPT/HCPCS codes on the IHCP PA form since care providers bill with revenue codes.
- Hospice election form
- MD signed certification for terminal illness with less than six months of life expectancy
Notification for all membersService: respite hospice Submit the following documentation by fax to 844-765-5157: - IHCP PA form, including:
- Enter a CPT/HCPCS code (one of the following codes must be listed: H0045, T1005, or T2044).
- If the respite service is for a nursing facility, hospice facility or a hospital, list the NPI and tax ID (enter in the note section of the PA form).
- Do not include revenue codes on the IHCP PA form.
- Your billing will not be impacted by listing the CPT/HCPCS codes on the IHCP PA form since care providers bill with revenue codes.
- Hospice election form..
- MD signed certification for terminal illness with less than six months of life expectancy
Note: Inpatient respite hospice is allowable only for members who are otherwise residing in a private home and are admitted to the indicated facility for a respite stay only. Notification for all membersService: general inpatient hospice related to the terminal illness Submit the following documentation by fax to 844-765-5157: - IHCP PA form, including:
- Enter a CPT/HCPCS code (one of the following codes must be listed: Q5005 or T2045).
- If the respite service is for a nursing facility, hospice facility or a hospital, list the NPI and tax ID (enter in the note section of the PA form).
- Do not include revenue codes on the IHCP PA form.
- Your billing will not be impacted by listing the CPT/HCPCS codes on the IHCP PA form since care providers bill with revenue codes.
- Hospice election form.
- MD signed certification for terminal illness with less than six months of life expectancy.
If the hospice provider has an arrangement with a facility to provide short-term inpatient care, the arrangement must be described in a written agreement. The written arrangement must meet the requirements of 42 CFR 418.108(c). Arranged services must be supported by written agreements as described in 42 CFR 418.100(e). These services are notification only, and no medical necessity review is conducted. With that, if any of the above elements are missing, Anthem will attempt to call the requesting care provider and/or fax the PA form back to the requesting care provider to submit the missing elements. Benefit periodsNotification of hospice services must be submitted for each of the benefit period 90-90-60 (see table below), then the open-ended services will begin with notification of the fourth benefit period. The face-to-face encounter must be submitted with the (fourth benefit period — open-ended benefit period). The open-ended benefit period will be open for two years. Please submit approximately 14 days before the authorization expires to fax number 844-765-5157. Period I | 90 days | Period II | 90 days (expected maximum length of time for illness to run its course) | Period II | Unlimited number of 60-day periods |
Open-ended hospice benefit period405 IAC 5-34-5 requires that a hospice physician or a hospice nurse practitioner must have a face-to-face encounter with a member receiving hospice care to determine continued eligibility for hospice care for the member’s third benefit period and every benefit period thereafter. The face-to-face encounter must occur not more than 30 calendar days before recertification of the third benefit period and of every subsequent benefit period. For hospice members in Healthy Indiana Plan, Hoosier Care Connect, and PathWays who require inpatient care, hospice care provider responsibilities depend on whether the stay is related to the terminal illness. For inpatient stays related to the terminal illness, at the general inpatient hospice level of service or the inpatient respite hospice level of service, the hospice care provider is responsible for the following: - Obtaining contracts with all IHCP care providers for arranged services:
- Reimbursing the facility according to the contract between the hospice care provider and the facility where the member receives care (Note: The contract between the hospice provider and the facility covers all costs related to the terminal illness.)
- Submitting claims directly to the MCE for reimbursement. (Note: The hospice care provider will be paid at the rate appropriate to the level of service provided to the hospice member; general inpatient hospice level of service will be reimbursed at the general inpatient rate; and inpatient respite hospice level of service will be reimbursed at the respite rate.)
For members receiving inpatient care unrelated to the terminal illness, the facility is responsible for: obtaining PA, as required, from the MCE; submitting claims directly to the MCE for reimbursement; all the member’s care and treatment while the member remains at the facility. For assistance with questions regarding the PA requirement change, please call Provider Services for the plan listed below. Provider Services | Hoosier Healthwise | 866-408-6132 | Healthy Indiana Plan | 844-533-1995 | Hoosier Care Connect | 844-284-1798 | Indiana PathWays for Aging | 833-569-4739 |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-064823-24 Prior Authorization | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | August 16, 2024 Prior authorization requirement changesEffective October 1, 2024 Effective October 1, 2024, the below CPT® codes will require prior authorization (PA). All covered services are contingent upon medical necessity and benefit coverage at the time of service. The PA lookup tool allows providers to search codes by the specific line of business (Medicaid/SCHIP/Family Care, or Hoosier Care Connect) to determine if PA is required and which guideline is utilized for the case review. To access the PA lookup tool, go to providers.anthem.com/in, and select Precertification Lookup Tool under the Claims drop-down. Contracted providers can also access the provider look up tool via Availity Essentials at Availity.com by selecting Payer Spaces and then selecting the Pre-cert Lookup tool tile. For assistance with questions regarding the PA requirement change, please call Provider Services at one of the phone numbers listed below: - Hoosier Healthwise — 866-408-6132
- Healthy Indiana Plan — 844-533-1995
- Hoosier Care Connect — 844-284-1798
- Indiana PathWays for Aging — 833-412-4405
CUMG number | CUMG title | CPT code | SG-CVS N204 | Cardiovascular Surgery or Procedure GRG NCD Implantable Cardioverter Defibrillators (ICDs) | 33263 | SG-CVS N204 | Cardiovascular Surgery or Procedure GRG NCD Implantable Cardioverter Defibrillators (ICDs) | 33264 | A-0973 SG-NS L38528 | Hypoglossal Nerve Stimulation, Implantable Neurosurgery or Procedure GRG LCD Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea | 64582 | A-0270 | Brachytherapy | C2616 | N2028 SG-NS SG-CVS | NCD Therapeutic Embolization Neurosurgery or Procedure GRG Cardiovascular Surgery or Procedure GRG | S2095 |
UM AROW A2024M141 Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-058750-24-CPN58059 Prior Authorization | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | August 13, 2024 Prior authorization requirement changesEffective October 1, 2024, the below CPT® codes will require prior authorization (PA). All covered services are contingent upon medical necessity and benefit coverage at the time of service. The PA lookup tool allows providers to search codes by the specific line of business (Medicaid/SCHIP/Family Care, or Hoosier Care Connect) to determine if PA is required and which guideline is used for the case review. To access the PA lookup tool, go to providers.anthem.com/in, and select the precertification lookup tool under the Claims drop-down menu. Contracted providers can also access the provider look up tool via Availity Essentials at Availity.com, selecting the Payer Spaces then select the pre-cert look up tool tile. For assistance with questions regarding the PA requirement change, please call Provider Services at one of the phone numbers listed below: - Hoosier Healthwise — 866-408-6132
- Healthy Indiana Plan — 844-533-1995
- Hoosier Care Connect — 844-284-1798
- Indiana PathWays for Aging — 833-412-4405
CUMG number | CUMG title | CPT code | MCG A-0487 MCG LCD L33787 CG-DME-13 | Lower Limb Prosthesis LCD Lower Limb Prosthesis Lower Limb Prosthesis; Lower Limb Accessories, Maintenance, Repairs, and Replacements | L5926 | MCG A-0487 MCG LCD L33787 CG-DME-13 | Lower Limb Prosthesis LCD Lower Limb Prosthesis Lower Limb Prosthesis; Lower Limb Accessories, Maintenance, Repairs, and Replacements | L5615 | MCG A-0974 MCG SG-NS | Phrenic Nerve Stimulation, Implantable Neurosurgery pr Procedure GRG | 33276 | MCG A-0974 MCG SG-NS | Phrenic Nerve Stimulation, Implantable Neurosurgery pr Procedure GRG | 33277 |
UM AROW A202M1495 and A202M1670 Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-059868-24 Prior Authorization | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | July 31, 2024 Prior authorization requirement changesEffective October 1, 2024 Effective October 1, 2024, the below CPT® codes will require prior authorization (PA). All covered services are contingent upon medical necessity and benefit coverage at the time of service. The PA lookup tool allows care providers to search codes by the specific line of business to determine if PA is required and which guideline is utilized for the case review. To access the PA lookup tool, go to providers.anthem.com/in, and select the Precertification Lookup Tool under the Claims drop-down. Contracted care providers can also access the provider look up tool via Availity Essentials at Availity.com select Payer Spaces, then select the Precertification Lookup Tool tile. For assistance with questions regarding the PA requirement change, call Provider Services at one of the phone numbers listed below: - Hoosier Healthwise — 866-408-6132
- Healthy Indiana Plan — 844-533-1995
- Hoosier Care Connect — 844-284-1798
UM AROW A2023M0965 Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-050746-24-CPN50188 Effective December 1, 2024 Effective December 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicare Advantage members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 0420U | Oncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2 in combination with droplet digital PCR (ddPCR) analysis of 6 single-nucleotide polymorphisms (SNPs) genes TERT and FGFR3, urine, algorithm reported as a risk score for urothelial carcinoma | 0422U | Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating DNA analysis using next-generation sequencing, algorithm reported as a quantitative change from baseline, including specific alterations, if appropriate Guardant360 Response™, Guardant Health, Inc, Guardant Health, Inc | 0423U | Psychiatry (eg, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition Genomind® Pharmacogenetics Report – Full, Genomind®, Inc, Genomind®, Inc | 0428U | Oncology (breast), targeted hybrid-capture genomic sequence analysis panel, circulating tumor DNA (ctDNA) analysis of 56 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutation burden Epic Sciences ctDNA Metastatic Breast Cancer Panel, Epic Sciences, Inc, Epic Sciences, Inc | 0430U | Gastroenterology, malabsorption evaluation of alpha-1-antitrypsin, calprotectin, pancreatic elastase and reducing substances, feces, quantitative Malabsorption Evaluation Panel, Mayo Clinic/Mayo Clinic Laboratories, Mayo Clinic/Mayo Clinic Laboratories | 0435U | Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on cytotoxicity percentage observed, minimum of 14 drugs or drug combinations ChemoID®, ChemoID® Lab, Cordgenics, LLC | 0790T | Revision (eg, augmentation, division of tether), replacement, or removal of thoracolumbar or lumbar vertebral body tethering, including thoracoscopy, when performed | 0810T | Subretinal injection of a pharmacologic agent, including vitrectomy and 1 or more retinotomies | 0815T | Ultrasound-based radiofrequency echographic multi-spectrometry (REMS), bone-density study and fracture-risk assessment, 1 or more sites, hips, pelvis, or spine | 0823T | Transcatheter insertion of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography | 0824T | Transcatheter removal of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography), when performed | 0825T | Transcatheter removal and replacement of permanent single-chamber leadless pacemaker, right atrial, including imaging guidance (eg, fluoroscopy, venous ultrasound, right atrial angiography and/or right ventriculography, femoral venography, cavography) and device evaluation (eg, interrogation or programming), when performed | 0826T | Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional, leadless pacemaker system in single-cardiac chamber | 0861T | Removal of pulse generator for wireless cardiac stimulator for left ventricular pacing; both components (battery and transmitter) | 0862T | Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; battery component only | 0863T | Relocation of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; transmitter component only | 0864T | Low-intensity extracorporeal shock wave therapy involving corpus cavernosum, low energy | 22836 | Anterior thoracic vertebral body tethering, including thoracoscopy, when performed; up to 7 vertebral segments | 22837 | Anterior thoracic vertebral body tethering, including thoracoscopy, when performed; 8 or more vertebral segments | 22838 | Revision (eg, augmentation, division of tether), replacement, or removal of thoracic vertebral body tethering, including thoracoscopy, when performed | 31242 | Nasal/sinus endoscopy, surgical; with destruction by radiofrequency ablation, posterior nasal nerve | 31243 | Nasal/sinus endoscopy, surgical; with destruction by cryoablation, posterior nasal nerve | 33276 | Insertion of phrenic nerve stimulator system (pulse generator and stimulating lead[s]), including vessel catheterization, all imaging guidance, and pulse generator initial analysis with diagnostic mode activation, when performed | 33279 | Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; transvenous stimulation or sensing lead(s) only | 33281 | Repositioning of phrenic nerve stimulator transvenous lead(s) | 33287 | Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator | 33288 | Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; transvenous stimulation or sensing lead(s) | 37242 | Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquired arterial malformations, arteriovenous malformations, arteriovenous fistulas, aneurysms, pseudoaneurysms) [when specified as genicular artery embolization] | 81517 | Liver disease, analysis of 3 biomarkers (hyaluronic acid [HA], procollagen III amino terminal peptide [PIIINP], tissue inhibitor of metalloproteinase 1 [TIMP-1]), using immunoassays, utilizing serum, prognostic algorithm reported as a risk score and risk of liver fibrosis and liver-related clinical events within 5 years Enhanced Liver Fibrosis™ (ELF™) Test, Siemens Healthcare Diagnostics Inc/Siemens Healthcare Laboratory LLC | 93150 | Therapy activation of implanted phrenic nerve stimulator system, including all interrogation and programming | 93151 | Interrogation and programming (minimum one parameter) of implanted phrenic nerve stimulator system | 93152 | Interrogation and programming of implanted phrenic nerve stimulator system during polysomnography | 93153 | Interrogation without programming of implanted phrenic nerve stimulator system | E0746 | Electromyograph Biofeedback | L5615 | Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control | Q4279 | Vendaje ac, per square centimeter | Q4287 | Dermabind dl, per square centimeter | Q4288 | Dermabind ch, per square centimeter | Q4289 | Revoshield + amniotic barrier, per square centimeter | Q4290 | Membrane Wrap-Hydro TM, per sq cm | Q4291 | Lamellas xt, per square centimeter | Q4292 | Lamellas, per square centimeter | Q4293 | Acesso dl, per square centimeter | Q4294 | Amnio quad-core, per square centimeter | Q4295 | Amnio tri-core amniotic, per square centimeter | Q4296 | Rebound matrix, per square centimeter | Q4297 | Emerge matrix, per square centimeter | Q4298 | Amnicore pro, per square centimeter | Q4299 | Amnicore pro+, per square centimeter | Q4300 | Acesso tl, per square centimeter | Q4301 | Activate matrix, per square centimeter | Q4302 | Complete aca, per square centimeter | Q4303 | Complete aa, per square centimeter | Q4304 | Grafix plus, per square centimeter |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider. Choose the Select a State ribbon and then find on the Resources tab. Contracted providers can also access Availity.com. UM AROW A2024M1469 Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-057223-24-CPN56904 The Federal Employee Program® (FEP) offers a quality reimbursement program for providers. Coding for CPT® II category codes for A1c results, blood pressure readings, and the first prenatal visit are reimbursed at $10 per code. The program has been a success in improving HEDIS® scores and data collection. The FEP Quality Reimbursement Program for PPO providers was revised as noted below effective May 12, 2023. Revisions to CPT II category II code requirements for $10 reimbursement:- Only professional HCFA billing providers
- Only these six places of service codes are applicable:
- 2 — telehealth not home
- 10 — telehealth home
- 11 — office
- 12 — home
- 17 — walk-in clinic
- 20 — urgent care
- Only a specific diagnosis code that coordinates with the applicable CPT II code
Submitting the claimSubmit the CPT II code in field 24 of the HCFA 1500 with a charge of $10. Use the applicable CPT II code, place of service code, and diagnosis code according to the information below. Blood pressure — systolic and diastolic readingsReimbursable DX codes: I10, I11.9, I12.9, I13.10, I15, I15.1, I15.8, I15.9, I16.0, I16.1, I16.9 3074F | Most recent systolic blood pressure less than 130 mm Hg | 3075F | Most recent systolic blood pressure 130-139 mm Hg | 3077F | Most recent systolic blood pressure greater than or equal to 140 mm Hg | 3078F | Most recent diastolic blood pressure less than 80 mm Hg | 3079F | Most recent diastolic blood pressure 80-89 mm Hg | 3080F | Most recent diastolic blood pressure greater than or equal to 90 mm Hg |
Hemoglobin A1cReimbursable DX codes: E10.8, E10.9, E11.8, E11.9 3044F | Most recent hemoglobin A1c (HbA1c) level less than 7.0% | 3046F | Most recent hemoglobin A1c (HbA1c) level greater than 9.0% | 3051F | Most recent hemoglobin A1c (HbA1c) level greater than or equal to 7.0% and less than 8.0% | 3052F | Most recent hemoglobin A1c (HbA1c) level greater than or equal to 8.0% and less than or equal to 9.0%
|
First prenatal visitThe first prenatal visit date of service must be on the claim (field 24A HCFA 1500) with the appropriate code. Reimbursable DX codes: Maternity-related diagnosis code 0500F | Initial prenatal care visit (report at first prenatal encounter with health care professional providing obstetrical care. Report also date of visit, and in a separate field, the date of the last menstrual period [LMP]) (Prenatal) | 0501F | Prenatal flow sheet documented in medical record by first prenatal visit (documentation includes at minimum blood pressure, weight, urine protein, uterine size, fetal heart tones, and estimated date of delivery). Report also: date of visit and, in a separate field, the date of the LMP (Note: If reporting 0501F prenatal flow sheet, it is not necessary to report 0500F Initial prenatal care visit) (Prenatal) |
For additional information about the FEP Quality Reimbursement Program, email us at FEPproviderGIC@anthem.com. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-063827-24-SRS63786, MULTI-BCBS-CM-064143-24-SRS63773 Anthem is excited to announce the development of the Blue National Physician Performance Dataset. This initiative is a collaborative approach between Blue Cross Blue Shield Association, Blue Health Intelligence (BHI), and Motive Medical Intelligence (MMI) to develop a consistent national approach to evaluating physicians at the National Provider Identifier (NPI) level that incorporates measures of quality of care, appropriateness of care, and cost/efficiency of care. Effective January 1, 2025, Anthem may incorporate the Blue National Physician Performance Dataset in various ways, including but not limited to: - Providing special opportunities to participate in product offerings.
- When members contact Anthem with requests for referral options.
- Developing provider designations in provider directory (FindCare) tools.
- Enhancing existing tools in FindCare and Cost Finder, such as Personalized Match, that assist members with identifying or sorting providers.
For more information on how physicians are evaluated within each of the three categories (quality, appropriateness, and cost), you can view the Blue National Physician Performance Dataset Evaluation Method. If you have any questions about the Methodology or your score, contact your local provider relationship management representative Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-059174-24-CPN57527, MULTI-BCBS-CM-059175-24-CPN57527 ATTACHMENTS (available on web): Blue National Physician Performance Dataset Evaluation Method (pdf - 0.11mb) Pharmacy | Commercial | August 26, 2024 Change to Prior Authorization Requirements Specialty pharmacy updates — September 2024The specialty pharmacy updates for Anthem are listed below. Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s medical specialty drug review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc. Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications. The inclusion of a National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code. Prior authorization updates Effective for dates of service on or after December 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process. Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® code(s) | CC-0264* | Anktiva (nogapendekin alfa inbekicept-pmln) | C9399, J9999 | CC-0166* | Hercessi (trastuzumab-strf) | J3590 | CC-0263* | Imdelltra (tarlatamab-dlle) | C9399, J9999 |
* Oncology use is managed by Carelon Medical Benefits Management. Site of care updates Update: In the May 2024 edition of Provider News, we announced the site of care review requirements for the following drugs would be effective August 1, 2024. Please be advised that the following drugs were not implemented to have SOC requirements added. Access our Clinical Criteria to view the complete information for these site-of-care updates. Clinical Criteria | Drug | HCPCS or CPT code(s) | CC-0042 | Bimzelx (bimekizumab-bkzx) | C9399, J3590 | CC-0256 | Rivfloza (nedosiran) | J3490 | CC-0257 | Wainua (eplontersen) | C9399, J3490 | CC-0254 | Zilbrysq (zilucoplan) | J3490 |
Step therapy updates Effective for dates of service on or after December 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. Access our Clinical Criteria to view the complete information for these step therapy updates. Clinical Criteria | Status | Drug | HCPCS or CPT code(s) | CC-0166 | Non-Preferred | Hercessi (trastuzumab-strf) | J3590 |
Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.
Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-065565-24-CPN65398 Effective for dates of service on or after December 1, 2024, the specialty Medicare Part B drugs listed below will be included in our precertification review process. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims. HCPCS or CPT® codes | Medicare Part B drugs | J1599 | Alyglo (immune globulin intravenous, human-stwk) |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-064688-24-CPN64482 Effective for dates of service on or after December 1, 2024, the specialty Medicare Part B drugs listed below will be included in our precertification review process. Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims. HCPCS or CPT® codes | Medicare Part B drugs | C9399, J9999 | Anktiva (nogapendekin alfa inbekicept-pmln) | J3590 | Hercessi (trastuzumab-strf) | C9399, J9999 | Imdelltra (tarlatamab-dlle) |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-064678-24-CPN64481 Pharmacy | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | August 9, 2024 New prior authorization and specialty pharmacy medical step therapy requirementsPrior authorization updatesEffective for dates of service on and after July 1, 2023, the following specialty pharmacy codes from current or new Clinical Criteria documents will require prior authorization. The list of Clinical Criteria is publicly available on our provider website. Visit the Clinical Criteria website to search for specific Clinical Criteria. Clinical Criteria | HCPCS codes | Drug(s) | CC-0072 | Q5126 | Alymsys (bevacizumab-maly) | CC-0107 | Q5126 | Alymsys (bevacizumab-maly) |
Step therapy updatesEffective for dates of service on and after July 1, 2023, the following specialty pharmacy code from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. Step therapy review will apply upon prior authorization initiation or renewal in addition to the current medical necessity review of the drug noted below. Clinical Criteria | Status | Drug(s) | HCPCS codes | CC-0107 | Non-preferred | Alymsys | Q5126 |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-029186-23 Want to reduce administrative burden and help your patients save on prescription costs? With real-time prescription benefit (RTPB), care providers can access patient-specific drug benefit information within the e-prescribing process. This functionality allows care providers to proactively identify barriers to cost and improve medication adherence. "Prescription pickup rates have increased 3.2% and saved patients on average $40 per prescription with using real-time prescription benefit.” — Surescripts.2 When using real-time prescription benefit during e-prescribing, care providers can see patient-specific benefit information including: - Formulary status of selected medication.
- Patient cost share of medication at a retail and mail order pharmacy.
- Up to five formulary drug alternatives.
- Coverage alerts, including prior authorization and step therapy.
Benefits you and your patients will experience when using RTPB:- Clearer, faster information
- Opportunity to lower cost barriers
- Decreased administrative burden
- Reduced time to therapy
- Enhanced patient experience
How real-time prescription benefit works:- Prescriber enters prescription information through e-prescribing.
- The e-prescribing system triggers a data call to the pharmacy benefit manager (PBM).
- The PBM receives the real-time prescription benefit request.
- The PBM delivers cost, formulary, and utilization information for the selected pharmacy back to the prescriber’s electronic health record (EHR).
- Prescriber and patient make a choice together.
Help your patients save money on their prescriptions with EHR access to patient-specific drug coverage and out of pocket costs. Find out if your EHR vendor provides real-time prescription benefits information. There’s no charge for the service; however, you will need the latest version of your EHR. References: - Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J. 2018;22:18-033. doi: 10.7812/TPP/18-033. PMID: 30005722; PMCID: PMC6045499.
- Giaquinto K. Prescription Pickup Rates 3.2 Percentage Points Higher with Surescripts Real-Time Prescription Benefit, Saving Patients an Average of $38 Per Prescription. Surescripts. September 2022.
- Rodriguez S. Surescripts real-time prescription benefit drove medication adherence. EHRIntelligence. https://ehrintelligence.com/news/surescripts-real-time-prescription-benefit-drove-medication-adherence?_hsmi=226935530&_hsenc=p2ANqtz--HlMXEGIqFp9czAfA3_Z5V1uCL8ujtrmfRv3mTJ3EhaA0VCsVpQQmK9ifNmgQw4ApI_6rb1_AvlNFyilc9FXXymEO4zpPLFQUikhqNsjxAAA_8INg. Published September 21, 2022. Accessed November 2, 2022.
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-065105-24 Visit the Drug Lists page on our website at anthem.com/ms/pharmacyinformation/home.html for more information about: - Copayment/coinsurance requirements and their applicable drug classes.
- Drug lists and changes.
- Prior authorization criteria.
- Procedures for generic substitution.
- Therapeutic interchange.
- Step therapy or other management methods subject to prescribing decisions.
- Any other requirements, restrictions, or limitations that apply to using certain drugs.
The commercial and exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October. To locate the exchange, select Formulary and Pharmacy Information and scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed. Federal Employee Program pharmacy updates and other pharmacy related information may be accessed at fepblue.org > Pharmacy Benefits. Please call provider services to request a copy of the pharmaceutical information available online if you do not have internet access. Through our efforts, we are committed to reducing administrative burden because we value you, our care provider partner. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-063546-24 To help make it as easy as possible to keep up with annual changes to HEDIS documentation, Anthem created a library of HEDIS content for you. You’ll find tip sheets with coding information and more for many HEDIS measures and other documentation to help ensure accurate claims coding, which helps ensure accurate reimbursement. Go to the Optimizing HEDIS & STARS category to view all the communications. HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CRCM-064528-24-CPN64263 |